All In Biotech

Free tool

FAERS Monitor: Lidoderm

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020612 or its brand name (Lidoderm, Lidocaine). Reports on generic versions are filed under their own applications.

Reports

57,026

Serious

40,998

72% of reports

Hospitalization

20,211

Death reported

5,778

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,078
  • pain3,849
  • nausea3,652
  • fatigue3,632
  • headache3,220
  • off label use2,920
  • dyspnoea2,617
  • diarrhoea2,388
  • pneumonia2,356
  • vomiting2,220
  • fall2,149
  • dizziness2,087
  • sinusitis2,059
  • death2,013
  • pyrexia1,846

Reports by year received

View as table
YearReports
2004307
2005302
2006422
2007435
2008539
2009652
2010886
20111,491
20121,671
20131,140
20141,548
20152,564
20164,104
20173,075
20183,825
20194,650
20205,794
20214,030
20223,737
20234,121
20244,117
20254,291
20263,321

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,997,133 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
sinusitisSignal2,0597.57.211,498
pneumoniaSignal2,3562.72.62,533
fallSignal2,1492.42.31,753
painSignal3,8492.32.22,956
pyrexia1,8462.01.9895
headache3,2201.91.81,404
vomiting2,2201.71.7718
fatigue3,6321.71.71,141
dyspnoea2,6171.71.6786
nausea3,6521.71.71,101
dizziness2,0871.51.5409
diarrhoea2,3881.41.3240
off label use2,9201.21.2131
drug ineffective4,0781.11.176
death2,0130.90.847

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.